Pereyra-Rodríguez, J., Domínguez Cruz, J., Armario Hita, J. C., & Ruíz Villaverde, R. (2021). 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain.
Citación estilo ChicagoPereyra-Rodríguez, José-Juan, Javier Domínguez Cruz, José Carlos Armario Hita, y Ricardo Ruíz Villaverde. 104-week Safety and Effectiveness of Dupilumab in the Treatment of Severe Atopic Dermatitis. The Experience of 5 Reference Dermatology Units in Spain. 2021.
Cita MLAPereyra-Rodríguez, José-Juan, Javier Domínguez Cruz, José Carlos Armario Hita, y Ricardo Ruíz Villaverde. 104-week Safety and Effectiveness of Dupilumab in the Treatment of Severe Atopic Dermatitis. The Experience of 5 Reference Dermatology Units in Spain. 2021.